Tabula Rasa HealthCare (NASDAQ:TRHC)’s share price hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $42.79 and last traded at $41.55, with a volume of 133592 shares traded. The stock had previously closed at $40.99.
A number of brokerages recently issued reports on TRHC. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $38.00 target price on the stock in a report on Thursday, January 11th. William Blair restated an “outperform” rating on shares of Tabula Rasa HealthCare in a report on Tuesday, March 13th. Citigroup began coverage on Tabula Rasa HealthCare in a report on Thursday, January 4th. They issued a “buy” rating on the stock. BidaskClub upgraded Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Thursday, March 22nd. Finally, Piper Jaffray lifted their target price on Tabula Rasa HealthCare to $43.00 and gave the stock an “overweight” rating in a report on Tuesday, March 13th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $36.40.
The company has a quick ratio of 1.11, a current ratio of 1.21 and a debt-to-equity ratio of 0.01. The firm has a market cap of $820.35, a price-to-earnings ratio of -1,067.75, a price-to-earnings-growth ratio of 9.11 and a beta of 2.34.
Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings results on Monday, March 12th. The company reported $0.09 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). Tabula Rasa HealthCare had a net margin of 10.63% and a negative return on equity of 1.96%. The business had revenue of $43.93 million for the quarter, compared to analysts’ expectations of $38.91 million. During the same quarter in the prior year, the firm posted $0.10 EPS. The business’s quarterly revenue was up 60.9% compared to the same quarter last year. sell-side analysts expect that Tabula Rasa HealthCare will post 0.18 earnings per share for the current fiscal year.
In other news, CEO Calvin H. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $34.75, for a total transaction of $278,000.00. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Bruce Luehrs sold 252,242 shares of Tabula Rasa HealthCare stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $34.29, for a total value of $8,649,378.18. The disclosure for this sale can be found here. Insiders have sold 324,000 shares of company stock worth $11,309,958 in the last quarter. 45.80% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRHC. Ranger Investment Management L.P. boosted its position in Tabula Rasa HealthCare by 896.7% during the fourth quarter. Ranger Investment Management L.P. now owns 777,341 shares of the company’s stock valued at $21,804,000 after purchasing an additional 699,352 shares during the last quarter. UBS Asset Management Americas Inc. acquired a new stake in Tabula Rasa HealthCare during the fourth quarter valued at $9,559,000. Peregrine Capital Management LLC acquired a new stake in Tabula Rasa HealthCare during the fourth quarter valued at $9,122,000. Castleark Management LLC acquired a new stake in Tabula Rasa HealthCare during the fourth quarter valued at $6,393,000. Finally, Hood River Capital Management LLC boosted its position in Tabula Rasa HealthCare by 17.1% during the fourth quarter. Hood River Capital Management LLC now owns 883,290 shares of the company’s stock valued at $24,776,000 after purchasing an additional 129,031 shares during the last quarter. 47.06% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Tabula Rasa HealthCare (TRHC) Hits New 1-Year High and Low at $42.79” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/23/tabula-rasa-healthcare-trhc-hits-new-1-year-high-and-low-at-42-79.html.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. The company provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.